Merlo Christoph, Trummler Michael, Essig Stefan, Zeller Andreas
Institute of Primary and Community Care, Schwanenplatz 7, 6004, Luzern, Switzerland.
Laboratories Bioanalytica, Maihofstrasse 95A, 6006, Luzern, Switzerland.
PLoS One. 2015 Sep 15;10(9):e0138613. doi: 10.1371/journal.pone.0138613. eCollection 2015.
As published data on 25-hydroxy-cholecalciferol (25(OH)D) deficiency in primary care settings is scarce, we assessed the prevalence of hypovitaminosis D, potential associations with clinical symptoms, body mass index, age, Vitamin D intake, and skin type in unselected patients from primary care, and the extent of seasonal variations of serum 25(OH)D concentrations.
METHODOLOGY/PRINCIPAL FINDINGS: 25(OH)D was measured at the end of summer and/or winter in 1682 consecutive patients from primary care using an enzyme-linked immunosorbant assay. Clinical symptoms were assessed by self-report (visual analogue scale 0 to 10), and vitamin D deficiency was defined as 25(OH)D concentrations < 50 nmol/l. 25(OH)D deficiency was present in 995 (59.2%) patients. 25(OH)D deficient patients reported more intense muscle weakness (visual analogue scale 2.7, 95% confidence interval 2.5 to 2.9) and had a higher body mass index (25.9kg/m2, 25.5 to 26.2) than non-deficient patients (2.5, 2.3 to 2.7; and 24.2, 23.9 to 24.5, respectively). 25(OH)D concentrations also weakly correlated with muscle weakness (Spearman's rho -0.059, 95% confidence interval -0.107 to -0.011) and body mass index (-0.156, -0.202 to -0.108). Self-reported musculoskeletal pain, fatigue, and age were not associated with deficiency, nor with concentrations. Mean 25(OH)D concentrations in patients with vitamin D containing medication were higher (60.6 ± 22.2 nmol/l) than in patients without medication (44.8 ± 19.2 nmol/l, p < 0.0001) but still below the targeted level of 75 nmol/l. Summer and winter 25(OH)D concentrations differed (53.4 ± 19.9 vs. 41.6 ± 19.3nmol/l, p < 0.0001), which was confirmed in a subgroup of 93 patients who were tested in both seasons (p = 0.01).
CONCLUSION/SIGNIFICANCE: Nearly 60% of unselected patients from primary care met the criteria for 25(OH)D deficiency. Self-reported muscle weakness and high body mass index were associated with lower 25(OH)D levels. As expected 25(OH)D concentrations were lower in winter compared to summer.
由于基层医疗环境中关于25-羟基胆钙化醇(25(OH)D)缺乏的公开数据稀缺,我们评估了基层医疗中未经挑选的患者维生素D缺乏症的患病率、与临床症状、体重指数、年龄、维生素D摄入量和皮肤类型的潜在关联,以及血清25(OH)D浓度的季节变化程度。
方法/主要发现:在夏末和/或冬末,使用酶联免疫吸附测定法对1682例连续的基层医疗患者进行了25(OH)D检测。通过自我报告(视觉模拟评分0至10)评估临床症状,维生素D缺乏定义为25(OH)D浓度<50 nmol/l。995例(59.2%)患者存在25(OH)D缺乏。与非缺乏患者相比(分别为2.5,2.3至2.7;以及24.2,23.9至24.5),25(OH)D缺乏患者报告有更严重的肌肉无力(视觉模拟评分2.7,95%置信区间2.5至2.9)且体重指数更高(25.9kg/m²,25.5至26.2)。25(OH)D浓度也与肌肉无力(斯皮尔曼等级相关系数-0.059,95%置信区间-0.107至-0.011)和体重指数(-0.156,-0.202至-0.108)弱相关。自我报告的肌肉骨骼疼痛、疲劳和年龄与缺乏症及浓度均无关联。服用含维生素D药物的患者的平均25(OH)D浓度(60.6±22.2 nmol/l)高于未服用药物的患者(44.8±19.2 nmol/l,p<0.0001),但仍低于目标水平75 nmol/l。夏季和冬季的25(OH)D浓度不同(53.4±19.9与41.6±19.3nmol/l,p<0.0001),这在93例两个季节均接受检测的亚组患者中得到证实(p=0.01)。
结论/意义:基层医疗中近60%的未经挑选的患者符合25(OH)D缺乏的标准。自我报告的肌肉无力和高体重指数与较低的25(OH)D水平相关。正如预期的那样,冬季的25(OH)D浓度低于夏季。